Why are Dali Raisin tablets expensive? What are the factors that affect pricing?

Daridorexant As a new generation of orexin receptor antagonist (DORA), is mainly used to treat insomnia and other diseases. Its selling price in the European and American markets is relatively high. This is mainly affected by multiple factors, including research and development costs, patent protection, market supply and demand, production costs, pricing strategies and medical insurance coverage.

First of all, R&D costs are a key factor affecting the pricing of DaliRasen. It often takes more than a decade and costs billions of dollars for a new drug to go from initial laboratory research to eventual release on the market. The research and development of DaliRasen involves neuroscience, clinical trials and long-term data tracking to ensure its safety, effectiveness and low addiction. The research and development of insomnia drugs is difficult, and many candidate drugs are eliminated in the early research stage. Therefore, pharmaceutical companies need to recoup the huge initial investment through higher prices.

Secondly, patent protection means that there will be no competition from generic drugs for a certain period of time. The patent period is usually 20 years. During this period, other pharmaceutical companies are unable to produce and sell generic drugs, so only original drugs are available on the market. This is also an important reason for the high price. Generally speaking, the price of a generic drug drops only after the patent expires and a generic drug becomes available.

The relationship between market supply and demand is also an important factor affecting prices. Insomnia is a common disease around the world, but for a long time, patients have had limited drug choices, especially for patients who have difficulty maintaining sleep. Traditional benzodiazepines and Z-drugs have side effects such as dependence and memory loss. Therefore, there is a huge market demand for DORA drugs such as Daliramin. On the supply side, due to limited production capacity in the early stages of new drug promotion, the imbalance between supply and demand has also pushed up prices.

Reference materials:https://www.quviviq.com/